首页 > 最新文献

Frontiers in Medicine最新文献

英文 中文
5-aminolevulinic acid induced photodynamic reactions in diagnosis and therapy for female lower genital tract diseases 5- 氨基乙酰丙酸诱导的光动力反应在女性下生殖道疾病诊断和治疗中的应用
Pub Date : 2024-07-15 DOI: 10.3389/fmed.2024.1370396
Yuqing Chen, Peng Guo, Lihong Chen, Dalin He
Since the patients suffering from female lower genital tract diseases are getting younger and younger and the human papilloma virus (HPV) infection is becoming more widespread, the novel non-invasive precise modalities of diagnosis and therapy are required to remain structures of the organ and tissue, and fertility as well, by which the less damage to normal tissue and fewer adverse effects are able to be achieved. In all nucleated mammalian cells, 5-Aminolevulinic acid (5-ALA) is an amino acid that occurs spontaneously, which further synthesizes in the heme biosynthetic pathway into protoporphyrin IX (PpIX) as a porphyrin precursor and photosensitizing agent. Exogenous 5-ALA avoids the rate-limiting step in the process, causing PpIX buildup in tumor tissues. This tumor-selective PpIX distribution after 5-ALA application has been used successfully for tumor photodynamic diagnosis (PDD) and photodynamic therapy (PDT). Several ALA-based drugs have been used for ALA-PDD and ALA-PDT in treating many (pre)cancerous diseases, including the female lower genital tract diseases, yet the ALA-induced fluorescent theranostics is needed to be explored further. In this paper, we are going to review the studies of the mechanisms and applications mainly on ALA-mediated photodynamic reactions and its effectiveness in treating female lower genital tract diseases.
由于女性下生殖道疾病患者越来越年轻化,人类乳头瘤病毒(HPV)感染也越来越普遍,因此需要新型非侵入性的精确诊断和治疗方法来保持器官和组织的结构以及生育能力,从而减少对正常组织的损伤和不良影响。在所有有核哺乳动物细胞中,5-氨基乙酰丙酸(5-ALA)是一种自发产生的氨基酸,它在血红素生物合成途径中进一步合成原卟啉 IX(PpIX),是一种卟啉前体和光敏剂。外源性 5-ALA 避免了这一过程中的限速步骤,导致 PpIX 在肿瘤组织中积聚。应用 5-ALA 后的这种肿瘤选择性 PpIX 分布已成功用于肿瘤光动力诊断(PDD)和光动力疗法(PDT)。一些基于 ALA 的药物已被用于 ALA-PDD 和 ALA-PDT 治疗包括女性下生殖道疾病在内的多种(癌前)疾病,但 ALA 诱导的荧光疗法仍有待进一步探索。本文将主要回顾 ALA 介导的光动力反应及其在治疗女性下生殖道疾病方面的机制和应用研究。
{"title":"5-aminolevulinic acid induced photodynamic reactions in diagnosis and therapy for female lower genital tract diseases","authors":"Yuqing Chen, Peng Guo, Lihong Chen, Dalin He","doi":"10.3389/fmed.2024.1370396","DOIUrl":"https://doi.org/10.3389/fmed.2024.1370396","url":null,"abstract":"Since the patients suffering from female lower genital tract diseases are getting younger and younger and the human papilloma virus (HPV) infection is becoming more widespread, the novel non-invasive precise modalities of diagnosis and therapy are required to remain structures of the organ and tissue, and fertility as well, by which the less damage to normal tissue and fewer adverse effects are able to be achieved. In all nucleated mammalian cells, 5-Aminolevulinic acid (5-ALA) is an amino acid that occurs spontaneously, which further synthesizes in the heme biosynthetic pathway into protoporphyrin IX (PpIX) as a porphyrin precursor and photosensitizing agent. Exogenous 5-ALA avoids the rate-limiting step in the process, causing PpIX buildup in tumor tissues. This tumor-selective PpIX distribution after 5-ALA application has been used successfully for tumor photodynamic diagnosis (PDD) and photodynamic therapy (PDT). Several ALA-based drugs have been used for ALA-PDD and ALA-PDT in treating many (pre)cancerous diseases, including the female lower genital tract diseases, yet the ALA-induced fluorescent theranostics is needed to be explored further. In this paper, we are going to review the studies of the mechanisms and applications mainly on ALA-mediated photodynamic reactions and its effectiveness in treating female lower genital tract diseases.","PeriodicalId":502302,"journal":{"name":"Frontiers in Medicine","volume":"27 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-07-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141647812","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Congenital anomalies of the kidney and urinary tract 肾脏和泌尿系统先天性异常
Pub Date : 2024-07-15 DOI: 10.3389/fmed.2024.1384676
Anfal Hussain Mahmoud, Iman M. Talaat, Abdelaziz Tlili, R. Hamoudi
Congenital Anomalies of the Kidney and Urinary Tract (CAKUT) refer to a range of conditions that affect the kidney and urinary tract. These anomalies can be severe, such as kidney agenesis, or milder, such as vesicoureteral reflux. CAKUT affects over 1% of live births and accounts for 40–50% of cases of chronic kidney failure in children. The pathogenesis of CAKUT is caused by various environmental, genetic, and epigenetic factors that disrupt normal nephrogenesis. Environmental factors that can lead to CAKUT include maternal diabetes, obesity, malnutrition, alcohol consumption, or medications affecting kidneys development. Genetic factors can cause an imbalance in the metanephros and the ureteric bud interaction. Defects in specific genes such as PAX2, TBX18, NRIP1, REX, SIX2, BMP4, and chromosome 17 cause CAKUT. Over 50 genes have been identified as the root cause of this condition, with monogenetic variants causing up to 20% of all cases. CAKUTs can be diagnosed through fetal ultrasonography, but some anomalies may remain undetected. GWASs, Next Generation Sequencing for targeted and whole exome DNA sequencing may provide additional diagnostic methods. This review article highlights some the leading factors that cause CAKUT, which adversely affects kidney development and urinary tract function.
先天性肾脏和泌尿道异常(CAKUT)是指影响肾脏和泌尿道的一系列疾病。这些异常可能很严重,如肾脏发育不全,也可能较轻,如膀胱输尿管反流。在活产婴儿中,CAKUT 的发病率超过 1%,占儿童慢性肾衰竭病例的 40-50%。CAKUT 的发病机制是由各种环境、遗传和表观遗传因素引起的,这些因素破坏了正常的肾脏生成过程。可导致 CAKUT 的环境因素包括母体糖尿病、肥胖、营养不良、饮酒或影响肾脏发育的药物。遗传因素可导致肾小球和输尿管芽相互作用失衡。PAX2、TBX18、NRIP1、REX、SIX2、BMP4 和 17 号染色体等特定基因的缺陷会导致 CAKUT。目前已确定有 50 多个基因是导致这种病症的根本原因,单基因变异导致的病例占所有病例的 20%。CAKUT 可通过胎儿超声波检查确诊,但有些异常可能仍未被发现。全球基因组分析、下一代测序的靶向和全外显子DNA测序可提供更多的诊断方法。本综述文章重点介绍了导致 CAKUT 的一些主要因素,这些因素会对肾脏发育和泌尿道功能产生不利影响。
{"title":"Congenital anomalies of the kidney and urinary tract","authors":"Anfal Hussain Mahmoud, Iman M. Talaat, Abdelaziz Tlili, R. Hamoudi","doi":"10.3389/fmed.2024.1384676","DOIUrl":"https://doi.org/10.3389/fmed.2024.1384676","url":null,"abstract":"Congenital Anomalies of the Kidney and Urinary Tract (CAKUT) refer to a range of conditions that affect the kidney and urinary tract. These anomalies can be severe, such as kidney agenesis, or milder, such as vesicoureteral reflux. CAKUT affects over 1% of live births and accounts for 40–50% of cases of chronic kidney failure in children. The pathogenesis of CAKUT is caused by various environmental, genetic, and epigenetic factors that disrupt normal nephrogenesis. Environmental factors that can lead to CAKUT include maternal diabetes, obesity, malnutrition, alcohol consumption, or medications affecting kidneys development. Genetic factors can cause an imbalance in the metanephros and the ureteric bud interaction. Defects in specific genes such as PAX2, TBX18, NRIP1, REX, SIX2, BMP4, and chromosome 17 cause CAKUT. Over 50 genes have been identified as the root cause of this condition, with monogenetic variants causing up to 20% of all cases. CAKUTs can be diagnosed through fetal ultrasonography, but some anomalies may remain undetected. GWASs, Next Generation Sequencing for targeted and whole exome DNA sequencing may provide additional diagnostic methods. This review article highlights some the leading factors that cause CAKUT, which adversely affects kidney development and urinary tract function.","PeriodicalId":502302,"journal":{"name":"Frontiers in Medicine","volume":"114 4","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-07-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141646776","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Editorial: Spotlight on the relationship between visual experience and myopia 社论:聚焦视觉体验与近视之间的关系
Pub Date : 2024-07-12 DOI: 10.3389/fmed.2024.1440572
Manrong Yu, Liqin Jiang, Jinhui Dai, Maria Liu
{"title":"Editorial: Spotlight on the relationship between visual experience and myopia","authors":"Manrong Yu, Liqin Jiang, Jinhui Dai, Maria Liu","doi":"10.3389/fmed.2024.1440572","DOIUrl":"https://doi.org/10.3389/fmed.2024.1440572","url":null,"abstract":"","PeriodicalId":502302,"journal":{"name":"Frontiers in Medicine","volume":"53 10","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-07-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141653066","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Editorial: Case reports in PET imaging 2023 社论:2023 年 PET 成像病例报告
Pub Date : 2024-07-10 DOI: 10.3389/fmed.2024.1455227
Carmelo Caldarella, M. Bauckneht, Ramin Sadeghi
{"title":"Editorial: Case reports in PET imaging 2023","authors":"Carmelo Caldarella, M. Bauckneht, Ramin Sadeghi","doi":"10.3389/fmed.2024.1455227","DOIUrl":"https://doi.org/10.3389/fmed.2024.1455227","url":null,"abstract":"","PeriodicalId":502302,"journal":{"name":"Frontiers in Medicine","volume":"36 8","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-07-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141661887","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Editorial: Insights in healthcare professions education: 2023 社论:医疗保健专业教育的启示:2023 年
Pub Date : 2024-07-09 DOI: 10.3389/fmed.2024.1438116
L. Monrouxe, Jacqueline Bloomfield
{"title":"Editorial: Insights in healthcare professions education: 2023","authors":"L. Monrouxe, Jacqueline Bloomfield","doi":"10.3389/fmed.2024.1438116","DOIUrl":"https://doi.org/10.3389/fmed.2024.1438116","url":null,"abstract":"","PeriodicalId":502302,"journal":{"name":"Frontiers in Medicine","volume":"39 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-07-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141665190","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Erratum: Artificial intelligence based data curation: enabling a patient-centric European health data space 勘误:基于人工智能的数据整理:打造以患者为中心的欧洲健康数据空间
Pub Date : 2024-07-09 DOI: 10.3389/fmed.2024.1455319
{"title":"Erratum: Artificial intelligence based data curation: enabling a patient-centric European health data space","authors":"","doi":"10.3389/fmed.2024.1455319","DOIUrl":"https://doi.org/10.3389/fmed.2024.1455319","url":null,"abstract":"","PeriodicalId":502302,"journal":{"name":"Frontiers in Medicine","volume":"78 14","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-07-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141664693","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Causal relationship between type 1 diabetes mellitus and mycoses: a Mendelian randomization study 1 型糖尿病与霉菌病之间的因果关系:孟德尔随机研究
Pub Date : 2024-06-14 DOI: 10.3389/fmed.2024.1408297
Xiaolan Chen, Chen Chen, Mingyan Wu, Shanmei Wang, Hongbin Jiang, Zhe Li, Yuetian Yu, Bing Li
Type 1 diabetes mellitus (T1DM) is frequently associated with various infections, including mycoses; however, the direct link between T1DM and fungal infections remains under-researched. This study utilizes a Mendelian randomization (MR) approach to investigate the potential causal relationship between T1DM and mycoses.Genetic variants associated with T1DM were sourced from the European Bioinformatics Institute database, while those related to fungal infections such as candidiasis, pneumocystosis, and aspergillosis were obtained from the Finngen database, focusing on European populations. The primary analysis was conducted using the inverse variance weighted (IVW) method, with additional insight from Mendelian randomization Egger regression (MR-Egger). Extensive sensitivity analyses assessed the robustness, diversity, and potential horizontal pleiotropy of our findings. Multivariable Mendelian randomization (MVMR) was employed to adjust for confounders, using both MVMR-IVW and MVMR-Egger to evaluate heterogeneity and pleiotropy.Genetically, the odds of developing candidiasis increased by 5% in individuals with T1DM, as determined by the IVW method (OR = 1.05; 95% CI 1.02–1.07, p = 0.0001), with a Bonferroni-adjusted p-value of 0.008. Sensitivity analyses indicated no significant issues with heterogeneity or pleiotropy. Adjustments for confounders such as body mass index, glycated hemoglobin levels, and white blood cell counts further supported these findings (OR = 1.08; 95% CI:1.03–1.13, p = 0.0006). Additional adjustments for immune cell counts, including CD4 and CD8 T cells and natural killer cells, also demonstrated significant results (OR = 1.04; 95% CI: 1.02–1.06, p = 0.0002). No causal associations were found between T1DM and other fungal infections like aspergillosis or pneumocystosis.This MR study suggests a genetic predisposition for increased susceptibility to candidiasis in individuals with T1DM. However, no causal links were established between T1DM and other mycoses, including aspergillosis and pneumocystosis.
1型糖尿病(T1DM)经常与包括真菌病在内的各种感染有关;然而,对T1DM与真菌感染之间的直接联系的研究仍然不足。与 T1DM 相关的基因变异来自欧洲生物信息研究所数据库,而与念珠菌病、肺囊肿病和曲霉菌病等真菌感染相关的基因变异则来自芬根数据库,重点研究欧洲人群。主要分析采用反方差加权法(IVW)进行,并从孟德尔随机化艾格回归(MR-Egger)中获得更多信息。广泛的敏感性分析评估了我们研究结果的稳健性、多样性和潜在的横向多义性。采用多变量孟德尔随机化(MVMR)调整混杂因素,同时使用MVMR-IVW和MVMR-Egger评估异质性和多义性。根据IVW方法确定,T1DM患者患念珠菌病的遗传几率增加了5%(OR = 1.05; 95% CI 1.02-1.07, p = 0.0001),Bonferroni调整后的P值为0.008。敏感性分析表明,异质性或多义性没有明显问题。对体重指数、糖化血红蛋白水平和白细胞计数等混杂因素的调整进一步支持了这些研究结果(OR = 1.08; 95% CI:1.03-1.13, p = 0.0006)。对包括 CD4 和 CD8 T 细胞以及自然杀伤细胞在内的免疫细胞计数的额外调整也显示出显著的结果(OR = 1.04;95% CI:1.02-1.06,p = 0.0002)。这项磁共振研究表明,T1DM 患者对念珠菌病的遗传易感性增加。然而,T1DM与曲霉菌病和肺囊肿病等其他真菌感染之间并没有因果关系。
{"title":"Causal relationship between type 1 diabetes mellitus and mycoses: a Mendelian randomization study","authors":"Xiaolan Chen, Chen Chen, Mingyan Wu, Shanmei Wang, Hongbin Jiang, Zhe Li, Yuetian Yu, Bing Li","doi":"10.3389/fmed.2024.1408297","DOIUrl":"https://doi.org/10.3389/fmed.2024.1408297","url":null,"abstract":"Type 1 diabetes mellitus (T1DM) is frequently associated with various infections, including mycoses; however, the direct link between T1DM and fungal infections remains under-researched. This study utilizes a Mendelian randomization (MR) approach to investigate the potential causal relationship between T1DM and mycoses.Genetic variants associated with T1DM were sourced from the European Bioinformatics Institute database, while those related to fungal infections such as candidiasis, pneumocystosis, and aspergillosis were obtained from the Finngen database, focusing on European populations. The primary analysis was conducted using the inverse variance weighted (IVW) method, with additional insight from Mendelian randomization Egger regression (MR-Egger). Extensive sensitivity analyses assessed the robustness, diversity, and potential horizontal pleiotropy of our findings. Multivariable Mendelian randomization (MVMR) was employed to adjust for confounders, using both MVMR-IVW and MVMR-Egger to evaluate heterogeneity and pleiotropy.Genetically, the odds of developing candidiasis increased by 5% in individuals with T1DM, as determined by the IVW method (OR = 1.05; 95% CI 1.02–1.07, p = 0.0001), with a Bonferroni-adjusted p-value of 0.008. Sensitivity analyses indicated no significant issues with heterogeneity or pleiotropy. Adjustments for confounders such as body mass index, glycated hemoglobin levels, and white blood cell counts further supported these findings (OR = 1.08; 95% CI:1.03–1.13, p = 0.0006). Additional adjustments for immune cell counts, including CD4 and CD8 T cells and natural killer cells, also demonstrated significant results (OR = 1.04; 95% CI: 1.02–1.06, p = 0.0002). No causal associations were found between T1DM and other fungal infections like aspergillosis or pneumocystosis.This MR study suggests a genetic predisposition for increased susceptibility to candidiasis in individuals with T1DM. However, no causal links were established between T1DM and other mycoses, including aspergillosis and pneumocystosis.","PeriodicalId":502302,"journal":{"name":"Frontiers in Medicine","volume":"108 9","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-06-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141342439","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Recent advancements in machine learning for bone marrow cell morphology analysis 用于骨髓细胞形态分析的机器学习的最新进展
Pub Date : 2024-06-14 DOI: 10.3389/fmed.2024.1402768
Yifei Lin, Qingquan Chen, Tebin Chen
As machine learning progresses, techniques such as neural networks, decision trees, and support vector machines are being increasingly applied in the medical domain, especially for tasks involving large datasets, such as cell detection, recognition, classification, and visualization. Within the domain of bone marrow cell morphology analysis, deep learning offers substantial benefits due to its robustness, ability for automatic feature learning, and strong image characterization capabilities. Deep neural networks are a machine learning paradigm specifically tailored for image processing applications. Artificial intelligence serves as a potent tool in supporting the diagnostic process of clinical bone marrow cell morphology. Despite the potential of artificial intelligence to augment clinical diagnostics in this domain, manual analysis of bone marrow cell morphology remains the gold standard and an indispensable tool for identifying, diagnosing, and assessing the efficacy of hematologic disorders. However, the traditional manual approach is not without limitations and shortcomings, necessitating, the exploration of automated solutions for examining and analyzing bone marrow cytomorphology. This review provides a multidimensional account of six bone marrow cell morphology processes: automated bone marrow cell morphology detection, automated bone marrow cell morphology segmentation, automated bone marrow cell morphology identification, automated bone marrow cell morphology classification, automated bone marrow cell morphology enumeration, and automated bone marrow cell morphology diagnosis. Highlighting the attractiveness and potential of machine learning systems based on bone marrow cell morphology, the review synthesizes current research and recent advances in the application of machine learning in this field. The objective of this review is to offer recommendations to hematologists for selecting the most suitable machine learning algorithms to automate bone marrow cell morphology examinations, enabling swift and precise analysis of bone marrow cytopathic trends for early disease identification and diagnosis. Furthermore, the review endeavors to delineate potential future research avenues for machine learning-based applications in bone marrow cell morphology analysis.
随着机器学习的发展,神经网络、决策树和支持向量机等技术正越来越多地应用于医学领域,尤其是涉及大型数据集的任务,如细胞检测、识别、分类和可视化。在骨髓细胞形态分析领域,深度学习因其鲁棒性、自动特征学习能力和强大的图像特征描述能力而具有巨大优势。深度神经网络是一种专为图像处理应用定制的机器学习范式。人工智能是支持临床骨髓细胞形态学诊断过程的有力工具。尽管人工智能在这一领域具有增强临床诊断的潜力,但人工分析骨髓细胞形态学仍是识别、诊断和评估血液病疗效的黄金标准和不可或缺的工具。然而,传统的人工方法并非没有局限性和缺点,因此有必要探索检查和分析骨髓细胞形态学的自动化解决方案。本综述从多维度阐述了骨髓细胞形态学的六个过程:骨髓细胞形态学自动检测、骨髓细胞形态学自动分割、骨髓细胞形态学自动识别、骨髓细胞形态学自动分类、骨髓细胞形态学自动计数和骨髓细胞形态学自动诊断。本综述强调了基于骨髓细胞形态学的机器学习系统的吸引力和潜力,综述了机器学习在这一领域应用的当前研究和最新进展。这篇综述的目的是为血液病学家提供建议,帮助他们选择最合适的机器学习算法来自动进行骨髓细胞形态学检查,从而快速、准确地分析骨髓细胞病理趋势,进行早期疾病识别和诊断。此外,这篇综述还努力为基于机器学习的骨髓细胞形态学分析应用勾勒出潜在的未来研究途径。
{"title":"Recent advancements in machine learning for bone marrow cell morphology analysis","authors":"Yifei Lin, Qingquan Chen, Tebin Chen","doi":"10.3389/fmed.2024.1402768","DOIUrl":"https://doi.org/10.3389/fmed.2024.1402768","url":null,"abstract":"As machine learning progresses, techniques such as neural networks, decision trees, and support vector machines are being increasingly applied in the medical domain, especially for tasks involving large datasets, such as cell detection, recognition, classification, and visualization. Within the domain of bone marrow cell morphology analysis, deep learning offers substantial benefits due to its robustness, ability for automatic feature learning, and strong image characterization capabilities. Deep neural networks are a machine learning paradigm specifically tailored for image processing applications. Artificial intelligence serves as a potent tool in supporting the diagnostic process of clinical bone marrow cell morphology. Despite the potential of artificial intelligence to augment clinical diagnostics in this domain, manual analysis of bone marrow cell morphology remains the gold standard and an indispensable tool for identifying, diagnosing, and assessing the efficacy of hematologic disorders. However, the traditional manual approach is not without limitations and shortcomings, necessitating, the exploration of automated solutions for examining and analyzing bone marrow cytomorphology. This review provides a multidimensional account of six bone marrow cell morphology processes: automated bone marrow cell morphology detection, automated bone marrow cell morphology segmentation, automated bone marrow cell morphology identification, automated bone marrow cell morphology classification, automated bone marrow cell morphology enumeration, and automated bone marrow cell morphology diagnosis. Highlighting the attractiveness and potential of machine learning systems based on bone marrow cell morphology, the review synthesizes current research and recent advances in the application of machine learning in this field. The objective of this review is to offer recommendations to hematologists for selecting the most suitable machine learning algorithms to automate bone marrow cell morphology examinations, enabling swift and precise analysis of bone marrow cytopathic trends for early disease identification and diagnosis. Furthermore, the review endeavors to delineate potential future research avenues for machine learning-based applications in bone marrow cell morphology analysis.","PeriodicalId":502302,"journal":{"name":"Frontiers in Medicine","volume":"55 34","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-06-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141339258","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Long-term prognosis in patients with thymoma combined with myasthenia gravis: a propensity score-matching analysis 胸腺瘤合并重症肌无力患者的长期预后:倾向得分匹配分析
Pub Date : 2024-06-14 DOI: 10.3389/fmed.2024.1407830
Kai Zhao, Yiming Liu, M. Jing, Wenhan Cai, Jiamei Jin, Zirui Zhu, Leilei Shen, Jiaxin Wen, Zhiqiang Xue
We aimed to assess the impact of myasthenia gravis (MG) on the long-term prognosis in patients with thymoma after surgery and identify related prognostic factors or predictors.This retrospective observational study included 509 patients with thymoma (thymoma combined with MG [MG group] and thymoma alone [non-MG group]). Propensity score matching was performed to obtain comparable subsets of 96 patients in each group. A comparative analysis was conducted on various parameters.Before matching, the 10-year survival and recurrence-free survival rates in both groups were 93.8 and 98.4%, and 85.9 and 93.4%, respectively, with no statistically significant difference observed in the survival curves between the groups (p > 0.05). After propensity score matching, 96 matched pairs of patients from both groups were created. The 10-year survival and recurrence-free survival rates in these matched pairs were 96.9 and 97.7%, and 86.9 and 91.1%, respectively, with no statistical significance in the survival curves between the groups (p > 0.05). Univariate analysis of patients with thymoma postoperatively revealed that the World Health Organization histopathological classification, Masaoka–Koga stage, Tumor Node Metastasis stage, resection status, and postoperative adjuvant therapy were potentially associated with tumor recurrence after thymoma surgery. Multivariate analysis demonstrated that the Masaoka–Koga stage and postoperative adjuvant therapy independently predicted the risk of recurrence in patients with thymoma after surgery.There was no difference in prognosis in patients with thymoma with or without MG. The Masaoka–Koga stage has emerged as an independent prognostic factor affecting recurrence-free survival in patients with thymoma, while postoperative adjuvant therapy represents a poor prognostic factor.
我们的目的是评估肌无力(MG)对胸腺瘤患者术后长期预后的影响,并找出相关的预后因素或预测因子。这项回顾性观察研究共纳入了509例胸腺瘤患者(胸腺瘤合并MG[MG组]和单纯胸腺瘤[非MG组])。研究人员对每组 96 名患者进行了倾向评分匹配,以获得具有可比性的子集。匹配前,两组患者的 10 年生存率和无复发生存率分别为 93.8% 和 98.4%,以及 85.9% 和 93.4%,组间生存曲线差异无统计学意义(P>0.05)。经过倾向评分匹配后,两组共有 96 对匹配患者。这些配对患者的 10 年生存率和无复发生存率分别为 96.9% 和 97.7%,以及 86.9% 和 91.1%,组间生存曲线差异无统计学意义(P > 0.05)。对胸腺瘤患者术后进行的单变量分析显示,世界卫生组织组织病理学分类、Masaoka-Koga分期、肿瘤结节转移分期、切除状态和术后辅助治疗与胸腺瘤术后肿瘤复发有潜在关联。多变量分析表明,Masaoka-Koga分期和术后辅助治疗可独立预测胸腺瘤患者术后复发的风险。Masaoka-Koga分期已成为影响胸腺瘤患者无复发生存期的独立预后因素,而术后辅助治疗则是不良预后因素。
{"title":"Long-term prognosis in patients with thymoma combined with myasthenia gravis: a propensity score-matching analysis","authors":"Kai Zhao, Yiming Liu, M. Jing, Wenhan Cai, Jiamei Jin, Zirui Zhu, Leilei Shen, Jiaxin Wen, Zhiqiang Xue","doi":"10.3389/fmed.2024.1407830","DOIUrl":"https://doi.org/10.3389/fmed.2024.1407830","url":null,"abstract":"We aimed to assess the impact of myasthenia gravis (MG) on the long-term prognosis in patients with thymoma after surgery and identify related prognostic factors or predictors.This retrospective observational study included 509 patients with thymoma (thymoma combined with MG [MG group] and thymoma alone [non-MG group]). Propensity score matching was performed to obtain comparable subsets of 96 patients in each group. A comparative analysis was conducted on various parameters.Before matching, the 10-year survival and recurrence-free survival rates in both groups were 93.8 and 98.4%, and 85.9 and 93.4%, respectively, with no statistically significant difference observed in the survival curves between the groups (p > 0.05). After propensity score matching, 96 matched pairs of patients from both groups were created. The 10-year survival and recurrence-free survival rates in these matched pairs were 96.9 and 97.7%, and 86.9 and 91.1%, respectively, with no statistical significance in the survival curves between the groups (p > 0.05). Univariate analysis of patients with thymoma postoperatively revealed that the World Health Organization histopathological classification, Masaoka–Koga stage, Tumor Node Metastasis stage, resection status, and postoperative adjuvant therapy were potentially associated with tumor recurrence after thymoma surgery. Multivariate analysis demonstrated that the Masaoka–Koga stage and postoperative adjuvant therapy independently predicted the risk of recurrence in patients with thymoma after surgery.There was no difference in prognosis in patients with thymoma with or without MG. The Masaoka–Koga stage has emerged as an independent prognostic factor affecting recurrence-free survival in patients with thymoma, while postoperative adjuvant therapy represents a poor prognostic factor.","PeriodicalId":502302,"journal":{"name":"Frontiers in Medicine","volume":"111 2","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-06-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141342491","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mechanisms and therapeutic research progress in intestinal fibrosis 肠纤维化的机理和治疗研究进展
Pub Date : 2024-06-14 DOI: 10.3389/fmed.2024.1368977
Yanjiang Liu, Tao Zhang, Kejian Pan, He Wei
Intestinal fibrosis is a common complication of chronic intestinal diseases with the characteristics of fibroblast proliferation and extracellular matrix deposition after chronic inflammation, leading to lumen narrowing, structural and functional damage to the intestines, and life inconvenience for the patients. However, anti-inflammatory drugs are currently generally not effective in overcoming intestinal fibrosis making surgery the main treatment method. The development of intestinal fibrosis is a slow process and its onset may be the result of the combined action of inflammatory cells, local cytokines, and intestinal stromal cells. The aim of this study is to elucidate the pathogenesis [e.g., extracellular matrix (ECM), cytokines and chemokines, epithelial-mesenchymal transition (EMT), differentiation of fibroblast to myofibroblast and intestinal microbiota] underlying the development of intestinal fibrosis and to explore therapeutic advances (such as regulating ECM, cytokines, chemokines, EMT, differentiation of fibroblast to myofibroblast and targeting TGF-β) based on the pathogenesis in order to gain new insights into the prevention and treatment of intestinal fibrosis.
肠纤维化是慢性肠道疾病的常见并发症,具有慢性炎症后纤维母细胞增生和细胞外基质沉积的特点,导致肠腔狭窄,肠道结构和功能受损,给患者生活带来不便。然而,目前抗炎药物普遍不能有效克服肠纤维化,因此手术成为主要的治疗方法。肠纤维化的发展是一个缓慢的过程,其发病可能是炎症细胞、局部细胞因子和肠基质细胞共同作用的结果。本研究旨在阐明肠纤维化的发病机制[如:细胞外基质(ECM)]、细胞外基质(ECM)、细胞因子和趋化因子、上皮-间质转化(EMT)、成纤维细胞向成肌纤维细胞的分化以及肠道微生物群]是肠纤维化发展的基础,本研究的目的是阐明其发病机制,并探索治疗进展(如调节 ECM、细胞因子、趋化因子、上皮-间质转化(EMT)、成纤维细胞向成肌纤维细胞的分化以及肠道微生物群)、细胞因子、趋化因子、EMT、成纤维细胞向肌成纤维细胞的分化以及靶向 TGF-β),从而获得预防和治疗肠纤维化的新见解。
{"title":"Mechanisms and therapeutic research progress in intestinal fibrosis","authors":"Yanjiang Liu, Tao Zhang, Kejian Pan, He Wei","doi":"10.3389/fmed.2024.1368977","DOIUrl":"https://doi.org/10.3389/fmed.2024.1368977","url":null,"abstract":"Intestinal fibrosis is a common complication of chronic intestinal diseases with the characteristics of fibroblast proliferation and extracellular matrix deposition after chronic inflammation, leading to lumen narrowing, structural and functional damage to the intestines, and life inconvenience for the patients. However, anti-inflammatory drugs are currently generally not effective in overcoming intestinal fibrosis making surgery the main treatment method. The development of intestinal fibrosis is a slow process and its onset may be the result of the combined action of inflammatory cells, local cytokines, and intestinal stromal cells. The aim of this study is to elucidate the pathogenesis [e.g., extracellular matrix (ECM), cytokines and chemokines, epithelial-mesenchymal transition (EMT), differentiation of fibroblast to myofibroblast and intestinal microbiota] underlying the development of intestinal fibrosis and to explore therapeutic advances (such as regulating ECM, cytokines, chemokines, EMT, differentiation of fibroblast to myofibroblast and targeting TGF-β) based on the pathogenesis in order to gain new insights into the prevention and treatment of intestinal fibrosis.","PeriodicalId":502302,"journal":{"name":"Frontiers in Medicine","volume":"28 17","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-06-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141342583","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Frontiers in Medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1